Recent years have witnessed groundbreaking progresses in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://antonfiki351676.actoblog.com/39751097/exploring-the-future-of-type-2-diabetes-treatment-retatrutide-and-trizepatide